Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis. [electronic resource]
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Oct 2011
- 3280-6 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1460-2385
10.1093/ndt/gfr127 doi
Adult Aged Aged, 80 and over Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--drug therapy Antibodies, Monoclonal, Murine-Derived--administration & dosage Antineoplastic Combined Chemotherapy Protocols--therapeutic use Cyclophosphamide--administration & dosage Female Follow-Up Studies Humans Kidney Diseases--drug therapy Male Middle Aged Prospective Studies Remission Induction Rituximab Treatment Outcome Young Adult